SOCS3 transactivation by PPARγ prevents IL-17-driven cancer growth
ContributorsBerger, Hélène; Végran, Frédérique; Chikh, Madijd; Gilardi, Federica; Ladoire, Sylvain; Bugaut, Hélène; Mignot, Grégoire; Chalmin, Fanny; Bruchard, Mélanie; Derangère, Valentin; Chevriaux, Angélique; Rébé, Cédric; Ryffel, Bernhard; Pot, Caroline; Hichami, Aziz; Desvergne, Béatrice; Ghiringhelli, François; Apetoh, Lionel
Published inCancer research, vol. 73, no. 12, p. 3578-3590
Publication date2013
Abstract
Keywords
- Animals
- Blotting, Western
- CD4-Positive T-Lymphocytes/drug effects/metabolism
- Cell Differentiation/drug effects
- Cell Line, Tumor
- Diet
- Docosahexaenoic Acids/administration & dosage/pharmacology
- Female
- Interleukin-17/metabolism
- Mammary Neoplasms, Experimental/genetics/pathology/prevention & control
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Mice, Knockout
- Mice, Nude
- PPAR gamma/agonists/genetics/metabolism
- Promoter Regions, Genetic/genetics
- RNA Interference
- Reverse Transcriptase Polymerase Chain Reaction
- Suppressor of Cytokine Signaling Proteins/genetics/metabolism
- Th17 Cells/drug effects/metabolism
- Transcriptional Activation
- Tumor Burden/drug effects/genetics
Research group
Citation (ISO format)
BERGER, Hélène et al. SOCS3 transactivation by PPARγ prevents IL-17-driven cancer growth. In: Cancer research, 2013, vol. 73, n° 12, p. 3578–3590. doi: 10.1158/0008-5472.CAN-12-4018
Main files (1)
Article (Published version)
Identifiers
- PID : unige:33010
- DOI : 10.1158/0008-5472.CAN-12-4018
- PMID : 23619236
ISSN of the journal0008-5472